The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.

MLA

Recknor, Christopher P., et al. “The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 30, no. 9, Sept. 2015, pp. 1717–25. EBSCOhost, https://doi.org/10.1002/jbmr.2489.

APA

Recknor, C. P., Recker, R. R., Benson, C. T., Robins, D. A., Chiang, A. Y., Alam, J., Hu, L., Matsumoto, T., Sowa, H., Sloan, J. H., Konrad, R. J., Mitlak, B. H., & Sipos, A. A. (2015). The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, 30(9), 1717–1725. https://doi.org/10.1002/jbmr.2489

Chicago

Recknor, Christopher P, Robert R Recker, Charles T Benson, Deborah A Robins, Alan Y Chiang, Jahangir Alam, Leijun Hu, et al. 2015. “The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 30 (9): 1717–25. doi:10.1002/jbmr.2489.